Kura Oncology, Inc. Research And Development Expense

• Kura Oncology, Inc. showed an increase of +47.7% in Research And Development Expense from 2024 to 2025.
• This data is from Kura Oncology, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), Kura Oncology, Inc.'s Research And Development Expense has grown by 850.1%.
• Historical annual values: Fiscal year 2025: $251.07 million | Fiscal year 2024: $169.97 million | Fiscal year 2023: $115.24 million | Fiscal year 2022: $92.81 million | Fiscal year 2021: $84.72 million | Fiscal year 2020: $60.40 million | Fiscal year 2019: $47.83 million | Fiscal year 2018: $46.79 million | Fiscal year 2017: $26.43 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026